Literature DB >> 630933

Human alveolar macrophage proteolytic enzyme activities in chronic obstructive pulmonary disease. Lack of correlation with functional abnormalities.

W L Coudon, J O Harris.   

Abstract

The occurrence of emphysema in people deficient in alpha1-antitrypsin and the production of emphysema in experimental animals with elastolytic enzymes suggest proteolysis as a mechanism for the development of emphysema. To investigate the possible role of pulmonary alveolar macrophages in the pathogenesis of emphysema, we measured elastase, acid protease, and elastase-like esterase activities in macrophages from patients with chronic obstructive lung disease and attempted to correlate the level of enzyme activity with the severity of pulmonary function abnormality measured in these patients. Compared to values for cigarette smokers with normal pulmonary function, these macrophage enzyme activities were not increased in patients with chronic obstructive lung disease, and there was no correlation of high elastase activity with more severe degrees of pulmonary function abnormality. These findings lead us to believe that the absolute level of proteolytic enzymes in pulmonary alveolar macrophages is not in itself a determinant of emphysema.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 630933     DOI: 10.1378/chest.73.3.364

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

1.  Enzymatic activities of bronchoalveolar lavages in coal workers pneumoconiosis.

Authors:  B Sablonniere; A Scharfman; J J Lafitte; A Laine; C Aerts; A Hayem
Journal:  Lung       Date:  1983       Impact factor: 2.584

2.  Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage.

Authors:  G W Hunninghake; J E Gadek; O Kawanami; V J Ferrans; R G Crystal
Journal:  Am J Pathol       Date:  1979-10       Impact factor: 4.307

3.  alpha 1-Antitrypsin deficiency and susceptibility to lung disease.

Authors:  H E Evans; N Bognacki
Journal:  Environ Health Perspect       Date:  1979-04       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.